Patent · US Active

Contraception method

US7749987B2 · kind B2 · utility

5Cited by
20References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2007
Grant dateJul 6, 2010
Priority date
Expiry dateMar 8, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S424/811
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of achieving contraception in a woman which comprises administering orally to said woman an estroprogestative composition comprising nomegestrol acetate and an estrogen is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.